Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: NIDDN(Non Insulin Dependent Diabetic Medication) Glycated Hemoglobin 7% TO 10% Michigan Neuropathy Screening Instrument (MNSI)-Examination Score 2.5/5 and MNSI Questionnaire Score 7/15 Consider Positive for the presence of Neuropathy Known Diabetes Participants Already on OHAs With or without medication for more than 5 years with Numbness,Burning sensation of foot and Pricking Pain in both Leg and Foot and toes.
Exclusion criteria
Exclusion criteria: IDDM(Insulin Dependent Diabetes Mellitus) Secondary Uncontrolled Hypertension (150 TO 90 MM HG) Vitamin B12 Deficiency CVA,Old CVA,Seizure disorder Gestational Diabetes Mellitus CKA and AKD Participants Varicose Veins, Non Healing Ulcers,Amputation/Surgery in Lower Limb Participans with lumbosacral radiculopathy testing Positive for Straight Leg Raising and Las Segue Sign
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of participants achieving a score of MNSi 2.5/5 and Questionnaire 7/15 as asseessed at baseline and end pointTimepoint: Baseline 0th day 30th day 60th day 90th day End point 120th day Base line 0 day 30th day 60th day 90th day End point 120th day | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparing the Bipthesiometry score from baseline to end point in patients who attained Minimal Clinically Important Difference(MCID) Difference in FBS,PPBS,HbA1c from baseline to endpoint Difference in HOMA-IR from baseline to end point Improvement in quality of life from baseline to end pointTimepoint: Baseline -0 day 30th day 60th day 90th day 120th day | — |
Countries
India
Contacts
National Institute of Siddha